“…n.a. (Nelson et al 2006) GP40/15 Glycoproteins that have a predicted 60 kDa precursor that is proteolytically cleaved into a 15 and 40 kDa protein probably by a subtilisin-like serine protease (CpSUB1); the GP60 locus is a highly polymorphic cluster and can be divided in two allelic groups Ia-Id (C. hominis), II (C. parvum); GalNAc-specific lectins such as HPA, AIA, and MPA prevent cell attachment and invasion indicating GPs might bind via GalNAc to cells; moreover Nac could reduce binding of the mAb against GP15 but not glucose, mannose or galactose; immunization of mice with mAb against GP15 could reduce oocyst shedding by 67.5%; GP15/GP40 are shed during gliding GP40: predicted N-terminal signal peptide, a polyserine domain, multiple predicted glycosylation sites, a single potential N-glycosylation site GP15: glycosylated, GPI anchor GP15 is localized on the surface of sporozoites and merozoites; GP40 is localized in the apical region whereas GP15 is found on the complete surface; since GP40 does not have a transmembrane domain or GPI anchor it is proposed that GP15 and GP40 form a complex (Tilley et al 1991;Jenkins et al 1993;Cevallos et al 2000a, b;Sestak et al 2002;O'Connor et al 2003O'Connor et al , 2007aWanyiri et al 2009Wanyiri et al , 2007 GP900 Ab against GP900 or subdomains reduced infection of cells in a concentration-dependent manner; GP900 mRNA levels peak at 14-26 h p.i. of cells; comparison of Ab reactivity between C. parvum and C. hominis against GP900 revealed that Ab did not cross-react between the species, indicating that morphological differences of surface molecules might account for species-specific infectivity Mucin-like glycoprotein composed of distal cysteine-rich domains separated by polythreonine domains and a large membrane proximal N-glycosylated core region; deglycosylated protein app.…”